NP
Narender Pal Singh
About Narender Pal Singh
Data last updated:
Narender Pal Singh is a Director at Ace Medipharma Private Limited (since 2009), Director at Belcourt Pharma Private Limited (since 2023) and Designated Partner at Medomak Healthcare Llp (since 2025). The companies operate in Pharma and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹2.30 Cr; the largest is Ace Medipharma Private Limited at ₹2.17 Cr (FY 2024). Earlier, Narender Pal Singh was a Director at Aab Assessors Private Limited (2004–2014) and Director at G M Fincap Ltd (from 2002).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 May 2009 | 2009 | ₹2.17 Cr (FY 2024) | Active | |
| Director | 20 Feb 2023 | 2023 | ₹13.3 Lakh (FY 2025) | Active | |
| Designated Partner | 08 Mar 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Feb 2004 | 1999 | ₹15.2 Lakh (FY 2024) | Active | |
| Director | 10 May 2002 | 1995 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Narender Pal Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Paramjot Singh | 07038000 | Ace Medipharma Private Limited , Belcourt Pharma Private Limited and 1 more | Director |
| Mohit Arora | 08660582 | Medomak Healthcare Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Narender Pal Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Narender Pal Singh
Narender Pal Singh currently holds 3 directorships: Ace Medipharma Private Limited (Director, since 11 May 2009, revenue ₹2.17 Cr (FY 2024)); Belcourt Pharma Private Limited (Director, since 20 Feb 2023, revenue ₹13.3 Lakh (FY 2025)); Medomak Healthcare Llp (Designated Partner, since 08 Mar 2025).
Narender Pal Singh was first appointed on 10 May 2002 as Director at G M Fincap Ltd. The most recent appointment on record is 08 Mar 2025 at Medomak Healthcare Llp.
The 2 current companies of Narender Pal Singh that report revenue have a combined latest revenue of ₹2.30 Cr: Ace Medipharma Private Limited ₹2.17 Cr (FY 2024); Belcourt Pharma Private Limited ₹13.3 Lakh (FY 2025).
Narender Pal Singh held 2 earlier board appointments: Aab Assessors Private Limited (Director, 27 Feb 2004 to 20 Aug 2014); G M Fincap Ltd (Director, from 10 May 2002).
The current boards of Narender Pal Singh's companies include Paramjot Singh (Ace Medipharma Private Limited), Mohit Arora (Medomak Healthcare Llp).